Shea E. Hogan, MD

Original Contribution

Retrospective Review of Directional Atherectomy and Drug-Coated Balloon Use in a PAD Safety-Net Population

04/01/2023

Shea E. Hogan , MD;

Matthew Holland , MD, FACC, FSCAI;

Joseph Burke , MD;

Paisley Johnson , MD;

Demetria McNeal , MD;

Lisa Cicutto , MD;

Mark Nehler , MD;

Pamela N. Peterson , MD, MSPH;

The authors retrospectively reviewed outcomes of patients with peripheral artery disease who underwent directional atherectomy and drug-coated balloon during lower extremity revascularization.

The authors retrospectively...

04/01/2023

Journal of Invasive Cardiology

Commentary

Preventing Contrast-Induced Nephropathy in Patients Undergoing Primary PCI

10/24/2011

Hitinder S. Gurm , MBBS, MD, FSCAI;

Shea E. Hogan , MD;

Contrast-induced nephropathy (CIN) continues to be one of the most common major adverse side effect of cardiac catheterization, and is associated with short- and long-term morbidity and mortality.1,2 This is particularly true in the...

Contrast-induced nephropathy...

10/24/2011

Journal of Invasive Cardiology